Typicality: | 0.456 |
Saliency: | 0.484 |
in approximately twelve xlmtm patients | 5 | other |
in west african populations | 4 | location |
primarily | 4 | degree |
trial → evaluate → the safety | 29 |
trial → assess → the safety | 13 |
trial → assess → its safety | 7 |
trial → examine → the safety | 7 |
trial → determine → the safety | 5 |
negative | neutral | positive |
0.035 | 0.825 | 0.140 |
Raw frequency | 61 |
Normalized frequency | 0.484 |
Modifier score | 0.500 |
Perplexity | 225.374 |